1798 related articles for article (PubMed ID: 26833491)
1. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
2. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Jíchová Š; Kopkan L; Husková Z; Doleželová Š; Neckář J; Kujal P; Vernerová Z; Kramer HJ; Sadowski J; Kompanowska-Jezierska E; Reddy RN; Falck JR; Imig JD; Červenka L
J Hypertens; 2016 Oct; 34(10):2008-25. PubMed ID: 27428043
[TBL] [Abstract][Full Text] [Related]
3. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats.
Jíchová Š; Doleželová Š; Kopkan L; Kompanowska-Jezierska E; Sadowski J; Červenka L
Am J Med Sci; 2016 Dec; 352(6):618-630. PubMed ID: 27916218
[TBL] [Abstract][Full Text] [Related]
5. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
[TBL] [Abstract][Full Text] [Related]
6. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Sedláková L; Kikerlová S; Husková Z; Červenková L; Chábová VČ; Zicha J; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Krátký V; Červenka L; Kopkan L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054426
[TBL] [Abstract][Full Text] [Related]
7. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD
Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
[TBL] [Abstract][Full Text] [Related]
8. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
[TBL] [Abstract][Full Text] [Related]
9. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Vanourková Z; Erbanová M; Thumová M; Opocenský M; Mullins JJ; Kramer HJ; Bürgelová M; Cervenka L
J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Kangussu LM; de Almeida TCS; Prestes TRR; de Andrade De Maria ML; da Silva Filha R; Vieira MAR; Silva ACSE; Ferreira AJ
Protein Pept Lett; 2019; 26(7):523-531. PubMed ID: 30950337
[TBL] [Abstract][Full Text] [Related]
11. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
Erbanová M; Thumová M; Husková Z; Vanecková I; Vanourková Z; Mullins JJ; Kramer HJ; Bürgelová M; Rakusan D; Cervenka L
J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811
[TBL] [Abstract][Full Text] [Related]
14. Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.
Howard CG; Mitchell KD
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F52-9. PubMed ID: 21993885
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
16. [ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Li SM; Wang XY; Liu F; Yang XH
Sheng Li Xue Bao; 2018 Apr; 70(2):175-183. PubMed ID: 29691582
[TBL] [Abstract][Full Text] [Related]
17. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
19. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.
Prieto MC; González-Villalobos RA; Botros FT; Martin VL; Pagán J; Satou R; Lara LS; Feng Y; Fernandes FB; Kobori H; Casarini DE; Navar LG
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F749-55. PubMed ID: 21209009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
